Medicare Coverage Analysis and Research Billing Compliance

1. Purpose

This SOP describes how [SITE NAME] decides which items and services in a clinical study may be billed to Medicare or other insurers as routine care and which must be paid by the sponsor or not charged at all, and how the site keeps research claims accurate. Billing an insurer for an item the sponsor already pays for, or for an item provided only for research, can create false claims liability. The coverage analysis and billing grid are the controls that prevent it.

2. Scope

This SOP applies to every study at [SITE NAME] in which any study-related item or service could be billed to Medicare, Medicare Advantage, Medicaid, a commercial insurer or a participant. It covers the coverage analysis, the billing grid, consistency checks across the CTA, budget and consent form, claim holds and review, and the claim coding required for research.

Sites that do not bill insurance. Many independent sites are paid only by the sponsor and never submit claims for study participants. If [SITE NAME] does not bill any insurer or participant for study items, the site follows the scaled-down process in 5.1 and does not need the full coverage analysis. The full process applies to any study where even one item will be billed.

Out of scope: budget negotiation (SOP-201) and participant payments (SOP-310). Where a sponsor, CRO or IRB requirement is stricter than this SOP, the site follows the stricter requirement. Payer rules change; the Quality Lead confirms the current CMS manual instructions and MAC guidance at each periodic review of this SOP.

This SOP describes operating steps. It is not legal advice; [SITE NAME] confirms legal and contracting positions with [LEGAL COUNSEL].

3. Responsibilities

4. Definitions

5. Procedure

5.1 Decide whether the site will bill for the study

• statement that [SITE NAME] will not bill any insurer or participant for any protocol item or service
• confirmation that the budget covers every item in the schedule of assessments
• confirmation that the consent form does not say any study item will be billed to the participant's insurance, and does not imply cost to the participant
• confirmation of how injury care is handled (CTA and consent form match, SOP-201)

5.2 Gather documents

5.3 Qualifying clinical trial determination (drugs, biologics and non-IDE studies)

• it evaluates an item or service that falls within a Medicare benefit category and is not statutorily excluded
• it has therapeutic intent and is not designed only to test toxicity or disease pathophysiology
• for therapeutic trials, it enrolls participants with the diagnosed disease rather than healthy volunteers (diagnostic trials may enroll healthy participants as a control group)

• funded by NIH, CDC, AHRQ, CMS, DoD or VA
• supported by centers or cooperative groups funded by those agencies
• conducted under an IND reviewed by FDA
• a drug trial exempt from an IND under 21 CFR 312.2(b)(1)

5.4 IDE device studies

• Category A: routine care items and services may be billed; the device may not
• Category B: routine care and the device may be billed, unless the sponsor provides the device free or reimburses it, in which case the device is not billed

5.5 Item-by-item determination

• the item and visit
• whether it is standard of care for this population at this frequency, with the basis (national guideline, NCD or LCD, published standard, PI attestation on site practice)
• whether the sponsor pays for it or provides it free under the budget or CTA
• the determination: sponsor-paid (S), routine and billable (R), research-only not billed (N), or not applicable

• the investigational item itself, unless otherwise covered outside the trial (for example a Category B device or an approved drug used on label, where coverage rules allow)
• items and services provided solely for data collection and not used in clinical management (for example extra pharmacokinetic draws, research-only imaging)
• items customarily provided free of charge by the sponsor
• any item or service the CTA budget pays for, even if it is also standard of care

5.6 Consistency across documents

• CA and budget. Every S item is paid in the budget. No R item is paid in the budget.
• CA and CTA. The CTA payment terms and subject injury terms match. Injury care the sponsor pays is not billed to Medicare.
• CA and consent form. The costs section of the consent form tells participants which items may be billed to their insurance and that they may owe copays and deductibles for those items, and that sponsor-paid and research-only items are free to them. Wording about injury costs matches the CTA.
• CA and billing grid. The billing grid reproduces the CA designations exactly.

5.7 Billing grid and amendments

5.8 Claims: flags, holds, coding and review

• Q1 modifier on routine clinical services; Q0 modifier on investigational clinical services that are billable (for example a covered Category B device)
• ICD-10-CM Z00.6 as a secondary diagnosis for qualifying clinical trials
• condition code 30 on institutional claims
• the NCT number: value code D4 on institutional claims; item 19 with the prefix CT on paper professional claims, or the equivalent electronic field (837P loop 2300 REF, qualifier P4) without the prefix
• the IDE number for device studies, in the field the MAC requires

5.9 Commercial insurance, Medicaid and Medicare Advantage

5.10 Monitoring and audit

5.11 Records

6. Related Forms and SOPs

• F-202-01 Coverage Analysis Worksheet
• F-204-01 Investigator Site File Index
• F-205-01 Study Activation Checklist
• F-700-02 Annual Audit Plan and Audit Report
• F-703-01 CAPA Record
• F-905-01 Cross-Entity Data Flow Register (Model N only)
• Appendix B Central and Site Responsibility Matrix (Model N only)
• SOP-105 Oversight of Service Providers and Vendors
• SOP-200 Study Feasibility and Selection
• SOP-201 Confidentiality Agreements, Clinical Trial Agreements and Budgets
• SOP-203 IRB Submissions, Approval and Continuing Oversight
• SOP-205 Site Qualification, Initiation and Study Activation
• SOP-301 Informed Consent Process and Documentation
• SOP-402 Record Retention, Archiving and Destruction
• SOP-703 Corrective and Preventive Action (CAPA)
• SOP-902 Network Study Feasibility, Allocation and Central Contracting (Model N only)
• SOP-903 Network Oversight of Member Sites (Metrics, Central QA, Escalation) (Model N only)
• SOP-904 Shared Staff, Cross-Site Coverage and Central Services (Model N only)

7. References